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Edited by Felix WielandAbstract Mature b-hexosaminidase A has been found associ-
ated to the external leaﬂet of plasma membrane of cultured
ﬁbroblasts. The plasma membrane association of b-hexosamini-
dase A has been directly determined by cell surface biotinylation
followed by aﬃnity chromatography puriﬁcation of the biotinyl-
ated proteins, and by immunocytochemistry. The immunological
and biochemical characterization of biotinylated b-hexosamini-
dase A revealed that the plasma membrane associated enzyme
is fully processed, suggesting its lysosomal origin.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Plasma membrane glycoconjugates show changes during
development and neoplastic transformation [1,2] suggesting a
speciﬁc role in cell–cell recognition. Glycosyl epitope changes
include many diﬀerent residues, such as GlcNAc, GalNAc in
N-linked structures or sialyl residues in either protein N-
linked, O-linked or lipid linked structures, so that cell surface
glycohydrolases could be one of the natural candidate for plas-
ma membrane glycosylation modiﬁcation.
For this reason, although in the past little attention was paid
to glycohydrolases acting on cellular compartment diﬀerent
from lysosomes, there is now increasing interest onplasmamem-
brane associated glycohydrolases because on this compartment
they should be involved, together with glycosyltransferases, in
GSL oligosaccharide modiﬁcation processes regulating cell-
to-cell and/or cell–environment interactions in both physiologi-
cal and pathological mechanisms [3–5].*Corresponding authors. Fax: +390250330365 (S. Sonnino);
+390755857443 (C. Emiliani).
E-mail addresses: emiliani@unipg.it (C. Emiliani),
sandro.sonnino@ unimi.it (S. Sonnino).
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that cleaves terminal b-linked GlcNAc or GalNAc residues
from oligosaccharides, glycolipids, glycoproteins and glycos-
aminoglycans. Two major lysosomal isoenzymes exist in
human tissues which are the products of the assembly of two
subunits, a and b, encoded by two closely related genes [6,7].
The two isoenzymes Hex A (ab) and Hex B (bb), diﬀer in their
substrate speciﬁcity. Both isoenzymes are able to hydrolyse
several natural and artiﬁcial substrates, but only Hex A, in
combination with a speciﬁc activator protein [8], can hydrolyse
GM2 ganglioside. b-Hexosaminidase precursors a and b
chains (pro-chains) are sorted out from trans-Golgi-network
(TGN) by mannose-6-phosphate receptors (MPR) after de
novo synthesis, and transported to lysosomes, where the two
subunits undergo ﬁnal processing to produce the complex
polypeptide structure of the mature enzyme [9]. A small part
of neo-synthetized b-hexosaminidase pro-chains escapes from
the direct transport to endosome/lysosomes and recycles via
cell-surface in a MPR-bound form [10].
In the present work we show the ﬁrst evidence for the pres-
ence of a fully processed b-hexosaminidase A (Hex A) associ-
ated to the external leaﬂet of the plasma membrane of human
ﬁbroblasts, with a direct approach by in vivo cell surface
biotinylation. Moreover we demonstrate its enzymatic activity
towards the natural substrate GM2 ganglioside.2. Materials and methods
2.1. Materials
Roswell Park Memorial Institute 1640 medium, Dulbeccos modi-
ﬁed Eagles medium (DMEM), foetal bovine serum (FBS), Trypsin,
Penicillin/Streptomicin were from Biochrom KG Seromed; 4-methyl-
umbelliferyl-b-N-acetylglucosaminide-6-sulphate (MUGS) was from
Toronto Research Chemicals Inc. 4-Methylumbelliferyl-b-N-acetyl-
glucosaminide (MUG), 4-methylumbelliferone, the detergents NP40
and Triton X-100; protease inhibitor cocktail for mammalian cell
extracts, monoclonal mouse anti-goat IgG HRP conjugate were from
Sigma-Aldrich Fine Chemicals Co. Alexa Fluor 488 rabbit anti-goat
IgG and Alexa Fluor 546 rabbit anti-mouse IgG were from Molecu-
lar Probes, Inc. Monoclonal mouse anti-LAMP-2 was from Santa
Cruz Biotechnology, Inc. Hybond-C Extra nitrocellulose, ECL Wes-
tern Blotting detection reagents and Sepharose-G-protein slurry wereation of European Biochemical Societies.
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protein assay reagent were from Bio-Rad Laboratories. Sulfosuccim-
idyl-6-(biotinamido)hexanoate (EZ-link Sulfo-NHS-LC-Biotin), Im-
munoPure Monomeric Avidin Kit and HRP-streptavidin were from
Pierce, Centricon YM-10 were from Amicon, Millipore. All other
reagents were of analytical grade. Gangliosides GM2 and GM3 were
prepared, characterized and tritium labelled at position 3 of erythro
C18-sphingosine as described [11–14]. The recombinant human
GM2 activator protein, GM2AP, was produced in Escherichia coli
[15].2.2. Cell cultures
Human ﬁbroblasts were cultured in DMEM medium containing
10% (v/v) heat inactivated FBS, penicillin 100 IU/ml/Streptomycin
100 lg/ml. Cell viability determined by Trypan blue method, under
the diﬀerential experimental conditions was about 95%.2.3. Immunocytochemical labelling of plasma membrane
b-hexosaminidase
Normal human ﬁbroblasts were plated onto glass coverslips and
grown for 24 h before labelling. Cells were washed with phosphate-buf-
fered saline (PBS) buﬀer and then ﬁxed with 4% paraformaldehyde/
PBS for 10 min at RT. After further washings cells were blocked and
permeabilized in 0.2% Triton X-100/PBS containing 10% (w/v) bovine
serum albumin (blocking solution) for 30 min at RT. Cells were then
treated with primary goat anti-human placental Hex A [16] and mouse
anti-LAMP-2 antibodies diluted in blocking solution. After washings
cells were incubated with Alexa Fluor 488 anti-goat IgG and Alexa
Fluor 546 anti-mouse IgG antibodies diluted in blocking solution.
For the restrictive plasma membrane staining, cells were incubated
exclusively with the antibody anti Hex A in the same conditions as
above, but without Triton X-100. Fluorescence microscopy was car-
ried out using a Nikon TE2000 microscope. Double labelling was also
examined by a confocal scanning microscope Nikon PCM2000.2.4. b-Hexosaminidase assays
b-Hexosaminidase activity was measured as previously described
[17] on artiﬁcial substrates MUG and MUGS. Fluorescence was
measured on a Perkin–Elmer LS B50 ﬂuorimeter (excitation, 360 nm;
emission, 446 nm). Optimum pH for b-hexosaminidase activity was
determined using the substrate MUG in 0.1 M citric acid/0.2 M diso-
dium phosphate buﬀers at diﬀerent pH values ranging from pH 3.5
to 7.5. One unit (U) is the amount of enzyme that hydrolyses 1 lmol
of substrate/min at 37 C. Protein content was determined [18] using
bovine serum albumin as a standard. Speciﬁc activity was expressed
as U/mg of protein. b-Hexosaminidase activity on natural substrate
was determined using [3H] GM2. The assay was performed using about
30 lg homogenate cell proteins or using puriﬁed plasma membrane
proteins corresponding to about one mU of enzyme, as determined
on MUG, in a ﬁnal volume of 50 ll of 10 mM, pH 4.2, citrate buﬀer,
containing 0.1% bovine albumin, 25 lg GM2AP, 13 lg of sodium taur-
odeoxycholate and 10.000 dpm of GM2 diluted in 3 lg cold GM2. The
enzyme reaction mixture was maintained at 37 C under continuous
vortexing for 12 h. The reaction mixture was mixed with 3 volumes
of tetrahydrofurane, the mixture was then centrifuged, the clear solu-
tion dried and the residue resuspended into a few ll of chloroform/
methanol 2:1 (v/v). The enzyme reaction mixtures were analyzed by
HPTLC followed by radioimaging and quantitative detection of the
separated GM2 and GM3.2.5. Biotinylation of cell surface proteins
Cells were washed three times with ice-cold 8 mMNa2HPO4/1.5 mM
KH2PO4, 2.7 mM KCl, 137 mM NaCl, pH 7.5 (Dulbeccos PBS) each
ﬂask of ﬁbroblasts was incubated, under gentle shaking, for 30 min at
4 C in 4 ml solution of EZ-Link Sulfo-NHS-LC-Biotin, dissolved in
PBS at the concentration of 0.5 mg/ml [19]. The reaction was termi-
nated by adding 4 ml of 100 mM Tris/HCl, pH 7.5. Cells were then
washed three times with PBS, and treated with the lysis buﬀer (0.1 M
sodium phosphate, 0.15 M NaCl, pH 7.2, containing 0.5% Triton X-
100 and protease inhibitor cocktail). After a 30 min incubation at room
temperature, cell homogenate was sonicated (four sonications, 15 s
each) and recovered and used for aﬃnity chromatography.2.6. Aﬃnity chromatography
Biotinylated proteins from ﬁbroblasts were puriﬁed by monomeric
avidin aﬃnity column chromatography, according to the manufacturer
instructions. Brieﬂy, the column (2 ml volume) was washed with 2 mM
biotin in 0.1 M sodium phosphate, 0.15 M NaCl, pH 7.2 (PBS) to
block any non-reversible biotin binding site contained in avidin resin.
The loosely bound biotin was removed with 0.1 M glycine pH 2.8; the
column was then equilibrated with PBS. Cell homogenate was loaded,
then the column was washed with PBS containing 0.1% Triton X-100
until all unbound protein had been washed oﬀ and the A280 returned to
baseline. Retained (biotinylated) protein was then eluted using 5 mM
D-biotin in PBS containing 0.1% Triton X-100. One ml fractions were
collected. Unretained and biotinylated proteins were pooled separately
and used for further characterizations.
2.7. Western blotting analysis of b-hexosaminidase polypeptides
Samples containing the same units of b-hexosaminidase were pre-
cipitated with 10% TCA and the resulting pellets subjected to 10%
SDS–PAGE under reducing conditions according to Laemmli [20].
Proteins were transferred to nitrocellulose, and the a and b peptides
of b-hexosaminidase recognized by immunoblotting using respec-
tively an antiserum speciﬁc for a-subunit, raised to a mixture of syn-
thetic peptides belonging to the sequence of mature human enzyme,
and an anti-b-subunit raised to Hex B puriﬁed from human placenta,
followed by enhanced chemiluminescence detection.
2.8. Immunoprecipitation studies
Biotinylated ﬁbroblasts were detached by scraping the cells in 1%
EDTA PBS. Cells were recovered by centrifugation and subjected to
three washes in ice-cold PBS. Fibroblasts from a 75 cm2 tissue culture
ﬂask were resuspended in 250 ll of lysis buﬀer and extracted as above
described. Cell homogenate, precleared with Sepharose-protein-G slur-
ry by rotation for 1 h at 4 C, was immunoprecipitated using the anti-
serum speciﬁc for b-subunit, previously bound to Sepharose-G-protein
slurry by rotation for 2.5 h at 4 C. After an overnight incubation at
4 C and centrifugation, immunocomplexes bound to Sepharose-pro-
tein-G slurry were extensively washed [21] and ﬁnally solubilized in
Laemmli sample buﬀer [20]. The same procedure was applied to not
biotinylated ﬁbroblasts. Biotinylated cell homogenate treated as above
but without antibody was used as negative control. Analysis of the
immunocomplexes was performed by Western blotting and bands
detected by incubating the ﬁlter for 1 h with HRP-streptavidin diluted
1:500 in PBS, pH 7.4, and ECL detection reagent.3. Results and discussion
Cell surface protein biotinylation, in vivo, followed by avidin
aﬃnity chromatography represents a good tool to purify plasma
membrane (PM) associated proteins. The procedure allowed us
to characterize a PM associated b-hexosaminidase avoiding
contamination of lysosomal activity and ‘‘in transit’’ isoen-
zymes during secretion.
The large majority of total cell b-hexosaminidase activity to-
wards artiﬁcial substrates, MUG (hydrolysed by both a- and
b-subunits) and MUGS (hydrolysed exclusively by a-subunit),
was not retained by the aﬃnity column. Nevertheless, a minor
enzyme activity was retained by the column and then recov-
ered as biotinylated fraction. From four diﬀerent experiments,
this activity represented 3–5% of total activity loaded on the
column and was displayed towards both substrates, MUG
and MUGS.
An additional evidence for the presence of b-hexosaminidase
on the outer leaﬂet of PM was achieved by immunocytochemi-
cal labelling of cells using a polyclonal antiserum, raised against
human placental HexA, followed by conventional (Fig. 1, panel
a) and confocal (Fig. 1, panel b) ﬂuorescence microscopy. To
speciﬁcally visualize the lysosomal compartment, cells were also
immunostained with the anti-LAMP-2 antibody.
Fig. 1. Immunoﬂuorescence detection of cell surface Hex A in human ﬁbroblasts. Panel a. Fluorescence microscopy. NP: double labelling in non
permeabilized cells (NP) with goat anti-human placental Hex A (Hex A) and mouse anti-human LAMP-2 (LAMP-2), antibodies. P: double labelling
in permeabilized cells (P) with goat anti-human placental Hex A antibody (P, Hex A) and mouse anti-human LAMP-2 (P, LAMP-2). Fluorescence
was analyzed using a Nikon TE2000 microscope. Magniﬁcation, 40·. Panel b. Confocal microscopy. Double labelling in permeabilized cells with
same antibodies as described in panel a. PM plan: Hex distribution (Hex A) is shown in green, LAMP-2 distribution (LAMP-2) in red and
colocalization of both proteins in yellow (overlay). N plan: Hex distribution (Hex A) is shown in green, LAMP-2 distribution (LAMP-2) in red and
colocalization of both proteins in yellow (overlay). Fluorescence was analyzed using a confocal scanning microscope Nikon PCM2000.
Magniﬁcation, 60·. Section thickness was 0.8 lm.
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bilized cells we had ﬂuorescence staining on the PM (Fig. 1,
panel a). Under similar conditions no staining was detected
for LAMP-2. Labelling performed on permeabilized cells
clearly detected the lysosomal enzyme and a minor quantity
associated to PM. In an experiment we pre-incubated cells 6
hr with cycloheximide, an inhibitor of protein biosynthesis.
Under this experimental conditions the PM associated label-
ling was not inhibited or modiﬁed (data not shown), indicating
that PM associated b-hexosaminidase has an half life longer
than 6 h. This result would exclude that cell surface b-hexosa-
minidase staining is due to MPR traﬃcking toward the mem-
brane. Confocal microscopy results (Fig. 1, panel b) conﬁrmed
the presence of hexosaminidase on PM. Plasma membrane
plan visualization showed a diﬀuse speciﬁc Hex A staining,
while only traces of LAMP-2 were visible (this last observation
is in agreement with that previous made by Eskelinen et al.
[22]). As expected, on the nucleus plan, intracellular LAMP-
2 staining completely merged with Hex A immunolabelling,
this highlighting the large lysosomal cell distribution of the
enzyme.Biotinylated proteins from human ﬁbroblasts puriﬁed by
aﬃnity chromatography were analyzed by Western blotting
using the two polyclonal antibodies speciﬁc for the a- and
b-subunit, respectively. Fig. 2 shows that both PM associated
and lysosomal a- and b-subunits displayed the same proteolitic
processing, indicating that the PM associated enzyme is in its
mature form. In fact, the anti a-subunit antibody recognized
in both the plasma membrane and soluble fraction a protein
displaying molecular mass of 54 kDa, while the anti b-subunit
antibody recognized in both cases a protein of 30 kDa [16].
These two values correspond to the fully processed subunits.
Immunoprecipitation experiments performed with anti b-
subunit antibody on the total homogenate from biotinylated
ﬁbroblasts, showed that both a- and b-subunit, respectively,
were present in the immunoprecipitate as biotinylated proteins
(Fig. 3), an evidence that mature Hex A isoenzyme (an a–b
dimer) is present on the cell surface.
PM associated b-hexosaminidase obtained by aﬃnity chro-
matography displayed optimal pH curves for activity towards
both MUG and MUGS substrates close to those of soluble
(fraction not-retained by the aﬃnity column) counterpart, with
Fig. 2. Western blotting analysis of cell homogenate and biotinylated
membrane-associated b-hexosaminidase. After cell surface protein
biotinylation, biotinylated proteins were separated by avidin aﬃnity
chromatography as reported in the experimental section, subjected to
SDS–PAGE and analyzed by Western blotting. (A) Immunostaining
with anti a-subunit antibody; (B) immunostaining with b-subunit
antibody. Lane 1, cell homogenate; lane 2, aﬃnity chromatography
unretained intracellular fraction; lane 3, aﬃnity chromatography
retained biotinylated membrane-associated fraction.
Fig. 3. Western blotting analysis of immunoprecipitated plasma
membrane associated Hex A. After cell surface biotinylation and cell
homogenization, proteins were immunoprecipitated with an anti b-
subunit polyclonal antibody. The immunoprecipitate was subjected to
SDS–PAGE and successive Western blotting analysis using HRP-
conjugated streptavidin. Lane 1, anti b-subunit immunoprecipitate
from biotinylated cells; lane 2, negative control; lane 3, anti b-subunit
immunoprecipitate from non biotinylated cells.
Fig. 4. pH Optimum curves of lysosomal and plasma-membrane
associated b-hexosaminidase. Hex A activity towards MUG was
determined in the pH range 3.5–7.5 in 0.1 M citric acid/0.2 disodium
phosphate buﬀer using aliquots of biotinylated membrane-associated
Hex A (s) and unretained intracellular Hex A (d). Results were
expressed as percentage of the maximum value, corresponding to
optimum pH, and are the mean of three independent experiments.
Fig. 5. Cell homogenate and plasma-membrane associated b-hexosa-
minidase activity on GM2 ganglioside The assay was performed in the
presence of the GM2 activator protein as reported in the experimental
section, after cell surface protein biotinylation and avidin aﬃnity
chromatography as reported in the experimental section. The total
enzyme reaction mixture was separated by TLC and radioactive lipids
were detected by digital autoradiography; 200–400 dpm were applied
on a 4 mm line; time of acquisition: 24 h. Lane 1, standard GM3; lane
2, negative control; lane 3, ﬁbroblast cell homogenate; lane 4, aﬃnity
chromatography retained biotinylated membrane-associated fraction;
lane 5, aﬃnity chromatography non-retained fraction.
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about 10% of the maximum enzyme activity is maintained
and this is true for both lysosomal and PM-associated hexos-
aminidases. Presence on the plasma membrane of glycohydro-
lases displaying an acidic optimum pH, is not a novelty. It has
already been demonstrated that human plasma-membrane-
associated sialidase NEU3 displays an acidic optimum pH
[23,24]. Acidic pH can be obtained in speciﬁc zones of the
external leaﬂet of the plasma membrane by plasma membrane
associated proteins such as Na+/H+ antiporter [25,26] or fol-
lowing segregation of acidic sialocompounds. It is well known
that on the plasma membrane some gangliosides can be highly
enriched, together with specialized proteins, in membrane lipid
domains [27].
Biotinylated b-hexosaminidase from ﬁbroblasts showed
enzymatic activity towards the natural substrate GM2 gangli-
oside in the presence of GM2 activator protein. Fig. 5 showsthat, in an in vitro assay, the GM2 ganglioside, containing
tritiated sphingosine, was transformed in GM3. This result
suggests the perspective of a potential functional role of PM
b-hexosaminidase in human ﬁbroblasts.
Like other lysosomal enzymes, after de novo synthesis, b-
hexosaminidase is transported from TGN to lysosomes, where
undergoes the ﬁnal proteolytic processing [9]. The presence of
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enzyme is delivered to PM from lysosomes. We can exclude
that the PM b-hexosaminidase is associated to the cell surface
by MPR interaction, because it is known that the lysosomal
enzymes loose the phosphate marker when they reach lyso-
somes [28]. Fusion events of lysosomes with the PM, in
response to a rise of cytosolic Ca2+, have been described as a
process for surface damage repairing [29,30].
Evidence supporting the existence of alternate targeting
mechanisms for lysosomes have been reported for a variety
of cell types including ﬁbroblasts [31,32]. Moreover a number
of lysosomal enzymes have been reported to associate with
lysosomal membranes by a M6P-independent mechanism
[33–35].
Our suggestion about the existence of a direct exchange of
b-hexosaminidase between lysosomes and PM, raises the issue
to explain how this enzyme can be both a lysosomal soluble
and membrane associated protein. To gain information about
this, we performed computer analysis along the primary struc-
ture of b-hexosaminidase subunits [36]. Results did not show
any multiple stretches of hydrophobic aminoacids and did
not suggest the possible addition of a glycosylphosphatidyli-
nositol anchor that could justify the association of Hex A to
PM. Nevertheless, we cannot exclude post transductional
modiﬁcations able to introduce into the protein small hydro-
phobic changes that allow interactions with the membrane
hydrophobic layer.
Evidences for membrane associated b-hexosaminidase acti-
vity has been provided in Drosophila melanogaster and in
Ascidia sperm, and a role for the enzyme in sperm-egg recog-
nition has been suggested [37–41]. In humans evidences are
limited to demonstration of hexosaminidase activity, detected
only by synthetic substrates, in PM enriched subcellular frac-
tion of peripheral blood lymphocytes and monocytes of mul-
tiple sclerosis patients, or of cancerous cells [42–44].
Our results, demonstrating the association to the extracellu-
lar leaﬂet of plasma membrane of a mature b-hexosaminidase
A, in combination with the information on other plasma
membrane associated glycohydrolases [5] is very attractive.
The fact that the enzyme is active toward gangliosides adds
speciﬁc interest to our information and new perspective for
the biological meaning of the presence of the enzyme at the
cell surface. In previous studies it has been demonstrated that
plasma membrane associated sialidase is capable to hydrolyse
gangliosides belonging to neighboring cells [5], thus determin-
ing the composition on the interacting surface. Gangliosides
are highly enriched in membrane lipid domains where their
concentration can participate to determine the correct acidic
pH necessary for the maximum enzyme hydrolysis. A speciﬁc
role of gangliosides to determine acidic conditions necessary
to biological processes was presented in the past [45,46]. This
sialidase hydrolyses the ganglioside Neu5Ac–Gal linkages
quite rapidly. Nevertheless, when the sialic acid belongs to
the trisaccharide sequence GalNAc–(Neu5Ac–)Gal, which is
known to be very rigid due to the strong interactions occur-
ring between the sialic acid lateral chain and the GalNAc res-
idue [47], it cannot be released by the enzyme. Thus, the
plasma membrane associated b-hexosaminidase can remove
the GalNAc residue preparing the substrate for a further
degradation.
According to this the availability of a pool of glycohydro-
lases associated to the plasma membrane allows structuralchanges of glycosphingolipids and changes of the organization
of membrane lipid domains in which gangliosides are highly
enriched. Membrane lipid domains segregate several proteins
belonging to the signalling processes and the glycolipid oligo-
saccharide modiﬁcations could be instrumental to regulate
cell-to-cell and/or cell–environment interactions in both phys-
iological and pathological mechanisms.
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